Bollore SE (BOLNV.PA) Fundamental Analysis & Valuation

EPA:BOLNV • FR001400XP40

Current stock price

5.247 EUR
-0.85 (-13.98%)
Last:

This BOLNV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BOLNV.PA Profitability Analysis

1.1 Basic Checks

  • In the past year BOLNV was profitable.
  • BOLNV had a positive operating cash flow in the past year.
  • BOLNV had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BOLNV had a positive operating cash flow.
BOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFBOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • BOLNV's Return On Assets of 6.15% is fine compared to the rest of the industry. BOLNV outperforms 74.47% of its industry peers.
  • The Return On Equity of BOLNV (14.99%) is better than 65.96% of its industry peers.
  • BOLNV has a Return On Invested Capital (0.75%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROIC 0.75%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
BOLNV.PA Yearly ROA, ROE, ROICBOLNV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • The Profit Margin of BOLNV (21.69%) is better than 91.49% of its industry peers.
  • In the last couple of years the Profit Margin of BOLNV has grown nicely.
  • BOLNV has a Operating Margin (2.75%) which is in line with its industry peers.
  • With a Gross Margin value of 32.15%, BOLNV is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BOLNV has declined.
Industry RankSector Rank
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
BOLNV.PA Yearly Profit, Operating, Gross MarginsBOLNV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BOLNV.PA Health Analysis

2.1 Basic Checks

  • BOLNV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BOLNV has about the same amount of shares outstanding.
  • BOLNV has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BOLNV has an improved debt to assets ratio.
BOLNV.PA Yearly Shares OutstandingBOLNV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BOLNV.PA Yearly Total Debt VS Total AssetsBOLNV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of 1.01, we must say that BOLNV is in the distress zone and has some risk of bankruptcy.
  • BOLNV has a Altman-Z score (1.01) which is comparable to the rest of the industry.
  • BOLNV has a debt to FCF ratio of 5.74. This is a neutral value as BOLNV would need 5.74 years to pay back of all of its debts.
  • BOLNV has a Debt to FCF ratio (5.74) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.13 indicates that BOLNV is not too dependend on debt financing.
  • BOLNV's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. BOLNV outperforms 70.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Altman-Z 1.01
ROIC/WACC0.13
WACC5.85%
BOLNV.PA Yearly LT Debt VS Equity VS FCFBOLNV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that BOLNV should not have too much problems paying its short term obligations.
  • BOLNV has a better Current ratio (1.18) than 68.09% of its industry peers.
  • A Quick Ratio of 1.08 indicates that BOLNV should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.08, BOLNV is doing good in the industry, outperforming 63.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.08
BOLNV.PA Yearly Current Assets VS Current LiabilitesBOLNV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BOLNV.PA Growth Analysis

3.1 Past

  • BOLNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 700.00%, which is quite impressive.
  • BOLNV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.57% yearly.
  • Looking at the last year, BOLNV shows a decrease in Revenue. The Revenue has decreased by -1.39% in the last year.
  • Measured over the past years, BOLNV shows a very negative growth in Revenue. The Revenue has been decreasing by -33.92% on average per year.
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -4.24% on average over the next years.
  • Based on estimates for the next years, BOLNV will show a very negative growth in Revenue. The Revenue will decrease by -46.45% on average per year.
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BOLNV.PA Yearly Revenue VS EstimatesBOLNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BOLNV.PA Yearly EPS VS EstimatesBOLNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. BOLNV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.20, which indicates a very decent valuation of BOLNV.
  • BOLNV's Price/Earnings ratio is rather cheap when compared to the industry. BOLNV is cheaper than 91.49% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BOLNV to the average of the S&P500 Index (27.87), we can say BOLNV is valued rather cheaply.
  • BOLNV is valuated quite expensively with a Price/Forward Earnings ratio of 57.72.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BOLNV is on the same level as its industry peers.
  • BOLNV is valuated rather expensively when we compare the Price/Forward Earnings ratio to 38.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
BOLNV.PA Price Earnings VS Forward Price EarningsBOLNV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOLNV is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, BOLNV is valued a bit cheaper than 72.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.1
EV/EBITDA 8.16
BOLNV.PA Per share dataBOLNV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • BOLNV's earnings are expected to decrease with -4.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.21%
EPS Next 3Y-4.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. BOLNV.PA Dividend Analysis

5.1 Amount

  • BOLNV has a Yearly Dividend Yield of 1.51%. Purely for dividend investing, there may be better candidates out there.
  • BOLNV's Dividend Yield is rather good when compared to the industry average which is at 1.12. BOLNV pays more dividend than 87.23% of the companies in the same industry.
  • BOLNV's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • The dividend of BOLNV has a limited annual growth rate of 3.53%.
Dividend Growth(5Y)3.53%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • BOLNV pays out 7.97% of its income as dividend. This is a sustainable payout ratio.
DP7.97%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
BOLNV.PA Yearly Income VS Free CF VS DividendBOLNV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BOLNV.PA Dividend Payout.BOLNV.PA Dividend Payout, showing the Payout Ratio.BOLNV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BOLNV.PA Fundamentals: All Metrics, Ratios and Statistics

Bollore SE

EPA:BOLNV (5/30/2025, 7:00:00 PM)

5.247

-0.85 (-13.98%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-17
Earnings (Next)07-28
Inst Owners11.91%
Inst Owner ChangeN/A
Ins Owners5.66%
Ins Owner ChangeN/A
Market Cap14.74B
Revenue(TTM)3.13B
Net Income(TTM)3.91B
Analysts77.5
Price Target5.88 (12.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.06
Dividend Growth(5Y)3.53%
DP7.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.59%
PT rev (3m)-11.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.3%
EPS NY rev (3m)-41.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85.67%
Revenue NY rev (3m)-85.67%
Valuation
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
P/S 0.82
P/FCF 13.1
P/OCF 8.85
P/B 0.56
P/tB 1.9
EV/EBITDA 8.16
EPS(TTM)0.64
EY12.2%
EPS(NY)0.09
Fwd EY1.73%
FCF(TTM)0.4
FCFY7.63%
OCF(TTM)0.59
OCFY11.29%
SpS6.42
BVpS9.3
TBVpS2.76
PEG (NY)N/A
PEG (5Y)0.16
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROCE 1.01%
ROIC 0.75%
ROICexc 0.88%
ROICexgc 1.59%
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
FCFM 6.24%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Debt/EBITDA 2.18
Cap/Depr 48.98%
Cap/Sales 2.99%
Interest Coverage 6.55
Cash Conversion 104.18%
Profit Quality 28.75%
Current Ratio 1.18
Quick Ratio 1.08
Altman-Z 1.01
F-Score7
WACC5.85%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.01%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A
EBIT growth 1Y17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-81.29%
EBIT Next 3Y-32.79%
EBIT Next 5YN/A
FCF growth 1Y70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.28%
OCF growth 3Y-52.89%
OCF growth 5Y-40.98%

Bollore SE / BOLNV.PA Fundamental Analysis FAQ

What is the fundamental rating for BOLNV stock?

ChartMill assigns a fundamental rating of 4 / 10 to BOLNV.PA.


What is the valuation status of Bollore SE (BOLNV.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to Bollore SE (BOLNV.PA). This can be considered as Fairly Valued.


How profitable is Bollore SE (BOLNV.PA) stock?

Bollore SE (BOLNV.PA) has a profitability rating of 5 / 10.


What is the valuation of Bollore SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for Bollore SE (BOLNV.PA) is 8.2 and the Price/Book (PB) ratio is 0.56.


What is the financial health of Bollore SE (BOLNV.PA) stock?

The financial health rating of Bollore SE (BOLNV.PA) is 5 / 10.